Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
18%
Ph phase_2
1
9%
Ph phase_3
8
73%

Phase Distribution

0

Early Stage

1

Mid Stage

8

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
8(72.7%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(11)

Detailed Status

Completed11

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (9.1%)
Phase 38 (72.7%)
N/A2 (18.2%)

Trials by Status

completed11100%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_3

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP

NCT00144547
completedphase_3

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP

NCT00144586
completedphase_2

Study of MRA in Patients With Rheumatoid Arthritis (RA)

NCT00144651
completedphase_3

Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

NCT00144625
completedphase_3

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

NCT00144612
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT00144547Phase 3

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP

Completed
NCT00144586Phase 3

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP

Completed
NCT00144651Phase 2

Study of MRA in Patients With Rheumatoid Arthritis (RA)

Completed
NCT00144625Phase 3

Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Completed
NCT00144612Phase 3

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Completed
NCT00380601Phase 3

PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)

Completed
NCT00144521Phase 3

Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)

Completed
NCT00144560Not Applicable

Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)

Completed
NCT00144573Not Applicable

Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment

Completed
NCT00144599Phase 3

Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Completed
NCT00144664Phase 3

Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11